Jonathan Leiken

CIK 1608984 · View on SEC EDGAR ↗

Insider

First SEC filing: March 3, 2026 · Latest: March 3, 2026

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 69 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

69 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
April 1, 2025 DLTR S 177 $75.56 $13,374 23,704 Direct -0.74% Disposed 78.4% (price as of 2026-08-19)
May 12, 2022 DBD P 4,400 $2.40 $10,560 269,108 Direct +1.66% Acquired 2743.3% (price as of 2026-08-19)
July 28, 2017 DBD P 2,000 $22.97 $45,940 33,985 Direct +6.25% Acquired 197.1% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Aug. 4, 2026 DHR Employee stock option (right to buy) Common Stock (92,138) $194.78 Aug. 4, 2036 92,138 Acquired
March 1, 2026 DHR Employee stock option (right to buy) Common Stock (6,416) $210.64 March 1, 2036 6,416 Acquired
Feb. 2, 2026 DHR Danaher Deferred Compensation Programs - Danaher Stock Fund [F1] Common Stock (41) 41 Acquired
Nov. 15, 2025 DHR Employee stock option (right to buy) Common Stock (26,767) $221.21 Nov. 15, 2035 26,767 Acquired
April 1, 2024 DLTR Stock Option (right to buy) Common Stock (5,406) $135.91 5,406 Acquired
Oct. 27, 2023 DLTR Stock Option (right to buy) Common Stock (2,697) $108.24 2,697 Acquired
Aug. 11, 2023 DBD Non-Qualified Stock Option [F3] Common Shares (12,048) $11.96 Jan. 30, 2030 12,048 Disposed
Aug. 11, 2023 DBD Non-Qualified Stock Option [F3] Common Shares (43,715) $4.08 Jan. 29, 2029 43,715 Disposed
Aug. 11, 2023 DBD Non-Qualified Stock Option [F3] Common Shares (24,517) $18.75 Feb. 1, 2028 24,517 Disposed
Aug. 11, 2023 DBD Non-Qualified Stock Option [F2] Common Shares (46,875) $26.60 Feb. 8, 2027 46,875 Disposed
Aug. 11, 2023 DBD Non-Qualified Stock Option [F2] Common Shares (24,581) $27.39 Feb. 3, 2026 24,581 Disposed
Aug. 11, 2023 DBD Non-Qualified Stock Option [F2] Common Shares (21,397) $32.33 Feb. 5, 2025 21,397 Disposed
Jan. 30, 2020 DBD Non-Qualified Stock Option [F5] Common Shares (12,048) $11.96 Jan. 30, 2030 12,048 Acquired
Jan. 29, 2019 DBD Non-Qualified Stock Option [F4] Common Shares (43,715) $4.08 Jan. 29, 2029 43,715 Acquired
Feb. 1, 2018 DBD Non-Qualified Stock Option [F1,F2] Common Shares (24,517) $18.75 Feb. 1, 2028 24,517 Acquired
Feb. 1, 2018 DBD Common Shares [F4] Common Shares (35,975) $18.75 Feb. 1, 2028 35,975 Acquired
Feb. 8, 2017 DBD Non-Qualified Stock Options [F3] Common Shares (46,875) $26.60 Feb. 7, 2027 46,875 Acquired
Feb. 3, 2016 DBD Non-Qualified Stock Option [F3] Common Shares (24,581) $27.39 Feb. 3, 2026 24,581 Acquired
Feb. 5, 2015 DBD Non-Qualified Stock Option [F3] Common Shares (21,397) $32.33 Feb. 5, 2025 21,397 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Aug. 27, 2025 DHR No securities are beneficially owned 0 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

DBD

Chief Legal Officer and Corporate Secretary
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2022 $30,714 $1,916,325
2021 $660,336 $23,704 $2,062,508
2020 $380,205 $23,466 $1,313,192

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.